Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

TMO – Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc
TMO
$585.51
Name : Thermo Fisher Scientific Inc
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $216,490,737,664.00
EPSttm : 18.5
finviz dynamic chart for TMO
Thermo Fisher Scientific Inc
$585.51
0.47%
$2.78
TMO — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.35

Margin Of Safety %

-15

Put/Call OI Ratio

0.87

EPS Next Q Diff

1.25

EPS Last/This Y

2.25

EPS This/Next Y

2.39

Price

585.59

Target Price

643.35

Analyst Recom

1.48

Performance Q

33.59

Upside

-30.2%

Beta

0.85

Ticker: TMO




21 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-20TMO526.280.950.7946164
2026-07-21TMO523.30.931.7449097
2026-07-22TMO526.340.940.9050400
2026-07-23TMO572.610.910.4755048
2026-07-24TMO568.250.891.2557634
2026-07-27TMO559.530.790.9449826
2026-07-28TMO576.280.800.5351745
2026-07-29TMO576.470.801.9952438
2026-07-30TMO576.490.810.7253438
2026-07-31TMO574.110.831.5554088
2026-08-03TMO574.040.791.8251555
2026-08-04TMO564.490.822.2253248
2026-08-05TMO577.410.842.2454128
2026-08-06TMO580.220.842.3554708
2026-08-07TMO593.890.830.9154782
2026-08-10TMO599.590.800.9654294
2026-08-11TMO6050.823.0655530
2026-08-12TMO603.050.830.4156018
2026-08-13TMO595.970.831.9356232
2026-08-14TMO588.030.845.9456725
2026-08-17TMO585.580.871.8756591
DateSymbolLatestP/C OIP/C VolTotal OI
21 items Current Page1 of 1




18 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-20TMO526.246.6-572.024.85
2026-07-21TMO523.306.6-528.924.85
2026-07-22TMO526.896.6-444.424.85
2026-07-23TMO572.466.6119.724.85
2026-07-24TMO568.106.6-494.924.85
2026-07-27TMO559.026.6-605.624.85
2026-07-28TMO576.4110.5-276.125.08
2026-07-29TMO576.5510.5-190.225.08
2026-07-30TMO576.5610.5-190.725.10
2026-07-31TMO574.2210.5-224.625.10
2026-08-03TMO573.9210.5-196.925.11
2026-08-04TMO573.9210.5-196.925.11
2026-08-05TMO577.2710.6-241.225.12
2026-08-06TMO580.2410.6-366.225.12
2026-08-07TMO593.9310.6-227.125.12
2026-08-13TMO595.8410.6-492.225.12
2026-08-14TMO588.2410.6-499.125.12
2026-08-17TMO585.5910.6-437.925.12
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
18 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-20TMO-1.81-2.811.44
2026-07-21TMO-1.81-2.811.44
2026-07-22TMO-1.81-2.811.44
2026-07-23TMO-1.81-2.811.44
2026-07-24TMO-1.81-2.811.44
2026-07-27TMO-1.81-2.521.43
2026-07-28TMO-1.81-2.521.43
2026-07-29TMO-1.85-2.521.43
2026-07-30TMO-1.71-2.521.43
2026-07-31TMO-1.71-2.521.43
2026-08-03TMO-1.71-2.721.43
2026-08-04TMO-1.71-2.721.43
2026-08-05TMO-1.72-2.721.44
2026-08-06TMO-1.72-2.721.44
2026-08-07TMO-1.72-2.721.44
2026-08-10TMO-5.69-2.811.44
2026-08-11TMO-5.69-2.811.44
2026-08-12TMO-5.09-2.811.35
2026-08-13TMO-7.19-2.811.35
2026-08-14TMO-7.19-2.811.35
2026-08-17TMO-7.19-3.031.35
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

6.03

Avg. EPS Est. Current Quarter

6.41

Avg. EPS Est. Next Quarter

7.28

Insider Transactions

-7.19

Institutional Transactions

-3.03

Beta

0.85

Average Sales Estimate Current Quarter

11951

Average Sales Estimate Next Quarter

12923

Fair Value

500.29

Quality Score

79

Growth Score

68

Sentiment Score

22

Actual DrawDown %

12.9

Max Drawdown 5-Year %

-41

Target Price

643.35

P/E

31.5

Forward P/E

21.36

PEG

2.2

P/S

4.67

P/B

4.11

P/Free Cash Flow

29.59

EPS

18.59

Average EPS Est. Cur. Y​

25.12

EPS Next Y. (Est.)

27.51

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.04

Relative Volume

0.4

Return on Equity vs Sector %

-13.2

Return on Equity vs Industry %

1.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.26

EBIT Estimation

-437.9
TMO Healthcare
$585.59
📉
Swing / Pullback
Buy the dip on strong trends
26 /100
WEAK
Trend
0/20
Pullback
2/25
Volume
11/15
Valuation
8/20
TP/AR
2/10
Options
3/10
RSI
61
Range 1M
81.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
31 /100
WEAK
Momentum
6/25
Growth
13/30
Estimates
4/20
Inst/Vol
4/15
Options
4/10
EPS Yr
9.8%
EPS NY
9.2%
52W%
72.5%
💎
Long-Term Value
Quality companies, undervalued
25 /100
WEAK
🔴 SELL -0.7% upside
Quality
9/30
Valuation
1/30
Growth
9/25
Stability
5/10
LT Trend
1/5
Upside
-0.7%
Quality
79
MoS
-15%
TMO — P/E HistoricalDiagnostics & Research
Thermo Fisher Scientific Inc
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 125000
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
TMO

Latest News

Caricamento notizie per TMO
stock quote shares TMO – Thermo Fisher Scientific Inc. Stock Price stock today
news today TMO – Thermo Fisher Scientific Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TMO – Thermo Fisher Scientific Inc. yahoo finance google finance
stock history TMO – Thermo Fisher Scientific Inc. invest stock market
stock prices TMO premarket after hours
ticker TMO fair value insiders trading